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In a case–control study of Campylobacter spp. risk fac-
tors in England during 2005–2006, we identified recent con-
sumption of commercially prepared chicken as an important 
risk factor. The risk for illness associated with recent chicken 
consumption was much lower for persons who regularly ate 
chicken than in those who did not, suggesting that partial 
immunologic protection may follow regular chicken prepara-
tion or consumption. Chicken-related risk factors accounted 
for 41% of cases; acid-suppressing medication, for 10%; 
self-reported past Campylobacter enteritis, 2%; and recent 
acquisition of a pet dog, 1%. Understanding the risks asso-
ciated with chicken from different sources will benefit strat-
egies to reduce Campylobacter infections. Better charac-
terization of immune correlates for Campylobacter infection 
is necessary to assess the relative importance of immunity 
and behavioral factors in determining risk.
Campylobacter spp. are the most common bacterial cause of enteritis in England. More than 40,000 cases 
are reported annually (1). Incidence of cases reported na-
tionally is ≈80 per 100,000 population, but the community 
incidence is ≈7× higher (2). Previously identified risk fac-
tors for Campylobacter enteritis include international trav-
el; ingestion of poultry, red meat, unpasteurized milk, and 
untreated water; contact with pets and farm animals; use of 
antimicrobial drugs and acid-suppressing medication; and 
diabetes (3–11).
Numerous studies implicate chicken consumption as 
an important risk factor for Campylobacter enteritis (6–18). 
However, some studies report associations specifically with 
eating undercooked chicken (5,6,12); others, with any type 
of chicken; and in 1 study, chicken consumption appeared 
to be protective (19). Other studies have found increased 
risks only with consumption of commercially prepared 
chicken (6–8,11,14,20).
One explanation for these disparities is that studies 
generally measure the average increase in risk from chick-
en consumption, without accounting for differences in in-
dividual susceptibility. We hypothesized that the frequency 
of chicken consumption modifies risk for Campylobacter 
enteritis associated with recent chicken consumption, pos-
sibly because persons who regularly eat chicken develop 
partial immunity to Campylobacter infection or because 
they have different consumption or preparation behaviors 
that influence risk for infection. We report the results of a 
multicenter case-control study in England designed to in-
vestigate food and other risk factors for reported Campy-
lobacter enteritis.
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Methods
Study Participants
Cases were laboratory-confirmed Campylobacter spp. 
infections in persons >18 years of age reported to 1 of 5 
English Health Protection Units (HPUs) (East Midlands 
North, Cheshire and Merseyside, Cumbria and Lancashire, 
North East and Central London, and Essex) from April 1, 
2005, through June 30, 2006. We randomly selected 5 con-
trols per case from records of all persons registered with 
primary care clinics in the area. Controls were stratum-
matched to cases by HPU, age group (18–34, 35–54, and 
>55 years), sex, and month of report.
Exclusion criteria were international travel in the 14 
days before illness for case-patients (or questionnaire com-
pletion for controls) and preexisting irritable bowel syn-
drome. Household clusters were identified by surname and 
postal address; only the first case in household clusters was 
included. Controls reporting gastrointestinal symptoms in 
the preceding 14 days also were excluded.
Case and Control Recruitment
We recruited case-patients by mail through their local 
Environmental Health Department or HPU and asked them 
to return a postage-paid self-completed risk factor ques-
tionnaire. We recruited controls by mail through the Health 
Protection Agency Centre for Infections and asked them 
to complete a similar questionnaire. Reminders were sent 
to nonresponders after 2 and 3 weeks. Signed, informed 
consent was obtained from participants.
Data Collection
We inquired about demographic information, clinical 
details, and risk factors in the 5 days before illness for cases 
and questionnaire completion for controls (i.e., 5-day fac-
tors). We also collected information about routine expo-
sures (i.e., habitual factors).
Statistical Analysis
Risk factors were grouped under 7 domains: health, 
occupation, pets, water, recreational exposures, food, and 
household details. We analyzed data by unconditional lo-
gistic regression by using Stata 8.2 software (Stata Corpo-
ration, College Station, TX, USA). ORs and 95% confi-
dence intervals (CIs) were calculated for each exposure. 
Analyses were adjusted for age group (18–24, 25–34, 
35–44, 45–54, 55–64, and >65 years), sex, study site, and 
calendar month. 
We powered our study to detect an odds ratio (OR) of 
1.4 for chicken consumption in the previous week (87% 
population prevalence (21), power = 0.8, α = 0.05), or an 
OR of 2.4 for an exposure with 1% prevalence.
Final Multivariable Model
Within each exposure domain, we first constructed a 
model comprising all habitual exposures. This model was 
simplified by using backward stepwise elimination until all 
remaining variables yielded likelihood ratio (LR) test re-
sults of p<0.05. This process was repeated for 5-day expo-
sure variables and conducted separately for each exposure 
domain.
Next, we fitted a model comprising all habitual vari-
ables identified in the domain-specific regressions and sim-
plified by backward stepwise elimination as before. A mod-
el for all 5-day exposures identified in the domain-specific 
regressions was similarly constructed.
Lastly, all habitual and 5-day factors from the above 
regressions were included in 1 model and the final model 
obtained by backward stepwise elimination. For all risk 
factors positively associated with disease, we also calcu-
lated the proportion of cases attributable to each risk factor 
(population-attributable fraction).
Chicken Consumption (Interaction Model)
We investigated further whether regular consump-
tion of chicken modified the risk for disease from recent 
chicken consumption. We classified participants according 
to whether they 1) regularly ate chicken (at least once a 
week) and 2) had eaten it in the previous 5 days. We further 
classified persons who had eaten chicken in the previous 5 
days according to whether they ate it in their own or some-
one else’s home, at a commercial establishment, or both. 
We fit a model with an interaction between these variables 
to investigate how the risk for disease varied in these sub-
groups relative to persons not exposed to chicken (defined 
as reporting they did not regularly eat chicken and had not 
eaten it in the previous 5 days). We assessed statistical evi-
dence for the interaction using the LR test. In a separate 
model, we additionally adjusted for all other risk factors 
identified in the multivariable analysis. Because of small 
numbers in some subgroups, this latter analysis could be 
performed only for persons who regularly ate chicken and 
reported eating it in the previous 5 days.
Sensitivity Analysis
For each of the final multivariable and interaction mod-
els, we conducted 2 sensitivity analyses. First, we repeated 
the analysis excluding case-patients for whom the delay 
between symptoms onset and questionnaire completion 
was longer than the median delay for all case-patients. We 
compared the ORs from this model to those from the model 
comprising all case-patients to explore potential effects of 
differential reporting of risk factors among late responders. 
In the interaction model, we could perform this analysis 
only for persons who regularly ate chicken and reported 
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eating it in the previous 5 days because of small numbers 
in other subgroups.
Second, by using an inverse probability-weighted ap-
proach (22), we investigated whether differences between 
participants and nonparticipants influenced results. We 
calculated individuals’ probabilities of participation from 
a 2-level random intercept logistic model regressing study 
participation against study site; a 3-way interaction between 
case and control status, age group, and sex; and area-level 
deprivation. To account for differences in area-level depri-
vation, we linked individuals’ postcodes to super output 
areas (SOAs), geographic boundaries comprising ≈1,000 
residents for which aggregated census data are available. 
SOAs are ranked according to the Index of Multiple De-
privation (23), which scores SOAs on 7 domains related 
to unemployment, income, education, housing, living envi-
ronment, crime, and healthcare access. We modeled area-
level deprivation using SOA as a latent, random intercept 
variable at the higher level. We then used the inverse prob-
abilities of participation from this model as weights in the 
final multivariable and interaction models, effectively giv-
ing more weight to persons in strata with low participation. 
We compared the ORs from the weighted and unweighted 
models to assess potential participation bias.
Ethical Approval
This study received a favorable ethical opinion from 
the North West Multicentre Research Ethics Committee. 
Approval was obtained from local research management 
and governance departments serving each study site.
Results
A total of 2,381 (46.5%) case-patients and 5,256 
(37.3%) controls returned questionnaires. Participants were 
excluded for the following reasons: missing age information 
(2 case-patients, 7 controls); chronic gastrointestinal illness 
(221 case-patients, 324 controls); gastrointestinal symptoms 
in the preceding 14 days (431); international travel in the 
preceding 14 days (560 case-patients, 511 controls); and 
being part of a household cluster of gastrointestinal illness 
(6 case-patients). After exclusions, 1,592 cases and 3,983 
controls were available for analysis. Among controls, 2,486 
(62.4%), 700 (17.6%), and 689 (17.3%) questionnaires were 
completed after the initial contact, first reminder, and second 
reminder respectively. Date of questionnaire completion was 
unknown or implausible for 108 controls.
Single-Variable Analysis
Habitual factors associated with increased risk were 
self-reported diarrheal illness in the previous 12 months; 
self-reported past Campylobacter enteritis; use of antimi-
crobial drugs, antacids and acid-suppressing medications in 
the previous 28 days; diabetes; puppy ownership; recent dog 
acquisition; chicken consumption at least once a week; red 
meat consumption once a week; and sharing of kitchen facil-
ities. Eating commercially prepared chicken in the previous 
5 days also was associated with increased risk (Table 1).
Habitual factors associated with decreased risk for ill-
ness were vegetarianism; regular consumption of salads, 
rice, and legumes; occupational exposure to sheep and 
horses; ownership of fish or rodents; and regular drinking 
of unpasteurized milk. Consumption of unpasteurized milk 
and dairy products, noncarbonated and carbonated bottled 
water, and unfiltered tap water in the previous 5 days also 
was associated with decreased risk.
Final Multivariable Model
In the final model, positively associated exposures were 
past Campylobacter enteritis (OR 2.2, 95% CI 1.3–3.6), 
recent use of acid-suppressing medication (OR 3.4, 95% 
CI 2.5–4.6), recent acquisition of a dog (OR 14.4, 95% CI 
3.7–54.1), regular consumption of chicken (OR 3.7, 95% 
CI 2.1–6.8 for those eating chicken >5 times a week), and 
consumption of commercially prepared chicken only in the 
previous 5 days (OR 2.0, 95% CI 1.3–3.0). Regular con-
sumption of salads, legumes, and unpasteurized milk and 
consumption of home-prepared chicken in the previous 5 
days were associated with decreased risk (Table 2).
Chicken Consumption (Interaction Model)
Statistical evidence was strong for an interaction be-
tween regular and recent chicken consumption (LR test p = 
0.0002) (Figure). Overall, persons who regularly ate chicken 
(at least once a week) were at greater risk for illness than 
those who did not (OR 1.6, 95% CI 1.2–2.0) (Figure, top). 
However, for persons who did not regularly eat chicken, eat-
ing it in the previous 5 days posed a 5-fold greater risk than 
it did for persons who did not (OR 5.0, 95% CI 2.1–11.9). 
We did not see this association for persons who regularly ate 
chicken (OR 0.8, 95% CI 0.6–1.0) (Figure, middle).
The risk associated with eating commercially prepared 
chicken was greater than that associated with eating home-
prepared chicken. Among persons who regularly ate chick-
en, eating commercially prepared chicken in the previous 5 
days was associated with a 4-fold increased risk (OR 4.0, 
95% CI 2.8–5.8) for Campylobacter infection, much higher 
than the risk associated with eating home-prepared chicken 
(OR 1.5, 95% CI 1.1–2.1). Among those who did not regu-
larly eat chicken, eating commercially prepared chicken 
was associated with a 36-fold increased risk (OR 35.7, 
95% CI 3.7–344.1); however, this group was very small 
(Figure, bottom).
Adjusting for nonchicken-related factors had little ef-
fect on the ORs (Table 2). The p values were considerably 
higher, although this analysis was based on fewer persons 
because of missing data in some variables.
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Sensitivity Analyses
Excluding late-responding case-patients had little ef-
fect on the ORs in either the final multivariable model or the 
interaction model. In the final multivariable model, ORs for 
eating chicken >1 times per week were consistently higher 
than in the model comprising all cases (OR 5.4, 95% CI 
2.3–12.4 for eating chicken >5 times per week).
In the inverse probability-weighted final model, the 
OR for eating commercially prepared chicken in the previ-
ous 5 days was 1.6 (95% CI 0.98–2.62). Other results did 
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Table 1. Final multivariable model of both habitual risk factors and risk factors for Campylobacter enteritis in the previous 5 days, 
adjusted for participant age group and sex, study site, and month of year, England, 2005–2006 
Exposure domain and variable Odds ratio 95% Confidence interval p value
Health details 
 Previous Campylobacter infection 2.20 1.33–3.64 0.002
 Use of acid-suppressing medication in previous  28 days 3.39 2.49–4.62 <0.001
Pets
 Pet fish 0.56 0.33–0.94 0.029
 If last pet acquired was a dog, how long ago was it acquired?
  Dog was not last pet bought/no pets 1.00 – –
>6 months ago 0.76 0.57–1.01 0.057
  3–6 months ago 1.30 0.53–3.16 0.566
  1–3 months ago 1.74 0.62–4.93 0.296
  2–4 weeks ago 14.40 3.69–56.14 <0.001
  <2 weeks ago 1.08 0.12–9.90 0.946
Food
 No. times salads eaten per week
  0 1.00 – –
  1 0.89 0.63–1.26 0.503
  2 0.58 0.40–0.82 0.002
  3 0.72 0.49–1.05 0.086
  4 0.93 0.62–1.40 0.739
>5 0.63 0.44–0.91 0.013
 No. times legumes eaten per week
  0 1.00 – –
  1 0.65 0.51–0.84 0.001
  2 0.57 0.44–0.75 <0.001
  3 0.47 0.33–0.68 <0.001
  4 0.65 0.40–1.05 0.078
>5 0.66 0.42–1.04 0.071
 No. times fruit eaten per week
  0 1.00 – –
  1 0.95 0.53–1.69 0.860
  2 1.57 0.96–2.55 0.071
  3 1.19 0.71–1.98 0.518
  4 1.77 1.05–2.98 0.032
>5 1.06 0.70–1.61 0.775
 No. times chicken eaten per week
  0 1.00 – –
  1 1.62 0.98–2.68 0.058
  2 1.96 1.16–3.32 0.012
  3 1.70 0.98–2.95 0.061
  4 2.10 1.16–3.79 0.014
>5 3.74 2.06–6.80 <0.001
 Regularly drinks raw milk 1.00 – –
  Rarely/never 
  Yes, regularly 0.24 0.08–0.72 0.010
  Yes, occasionally 0.70 0.33–1.51 0.365
 Location where chicken eaten in past 5 days was prepared
  No chicken eaten 1.00 – –
  In the home/someone else's home only 0.70 0.49–1.00 0.050
  Outside the home only 1.95 1.26–3.01 0.003
  In the home and outside the home 0.70 0.48–1.03 0.069
RESEARCH
not change. In the interaction model, the weighted model 
indicated stronger evidence for associations with eating 
home-prepared chicken (OR 1.76, 95% CI 1.22–2.29, p = 
0.001) and eating home-prepared and commercially pre-
pared chicken in the previous 5 days (OR 1.63, 95% CI 
1.18–2.25, p = 0.003), compared with the unweighted re-
sults (Table 1).
Population-Attributable Fractions
Chicken-related exposures were reported by 92.5% of 
controls; use of acid-suppressing medications, by 6.0%; 
past Campylobacter enteritis, by 2.2%; and recent acquisi-
tion of a dog, by 1.6%. The percentage of cases attribut-
able to each of these risk factors (Table 3) was as follows: 
chicken-related exposures, 41%; acid-suppressing medica-
tions, 10%; past Campylobacter enteritis, 3%; and recent 
acquisition of a dog, 1%.
Discussion
Chicken consumption and use of acid-suppressing 
medications are major risk factors for Campylobacter en-
teritis in England. Chicken-related exposures accounted 
for 41% of adult cases, consistent with previous US and 
Australian studies (5,8,24). Recent use of acid-suppressing 
medications increased risk for illness 3-fold, similar to oth-
er studies (9), accounting for 10% of cases.
Like others (3,6–8,11), we found that commercially 
prepared chicken poses a greater risk than home-prepared 
chicken. Reasons might be greater contamination levels or 
inadequate cooking procedures, which could be more com-
mon in commercial establishments than in homes. Howev-
er, we found only modest increases in risk for persons who 
ate home-prepared and commercially prepared chicken, 
suggesting that persons who regularly eat chicken at home 
frequent different types of establishments than do persons 
who tend to eat chicken only outside the home. We could 
not investigate this hypothesis further.
Several findings suggest that acquired immunity might 
be important. The risk for Campylobacter enteritis associ-
ated with recent chicken consumption depended on wheth-
er participants regularly ate chicken. For persons who ate 
chicken in the previous 5 days, the risk was considerably 
greater for those who did not regularly eat chicken than 
for those who did. Recent, but not longer-term, dog owners 
had higher risk for illness, whereas persons who regularly 
drank unpasteurized milk had decreased risk. We could not 
confirm participants’ immunologic status; however, these 
results suggest that long-term exposure to these sources of 
Campylobacter spp. might confer partial immunity (25). 
In immunologically susceptible populations, however, 
unpasteurized milk is a well-known cause of outbreaks of 
infection with Campylobacter and potentially fatal Shiga–
toxin producing Escherichia coli (26). Further develop-
ments to characterize relevant correlates of immune status 
for Campylobacter infection are required to confirm these 
findings.
Despite the potential role of immunity, participants re-
porting previous Campylobacter enteritis, but not nonspecif-
ic enteritis, had greater risk for recent Campylobacter illness 
1406 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009
Table 2. Comparison of increased risks for Campylobacter enteritis associated with eating chicken in the previous 5 days in persons 
who regularly ate and never ate chicken, England, 2005–2006* 
Regularly eats chicken Ate chicken in previous 5 days Location where chicken was prepared OR† 95% CI p value
No No – 1.00 – –
Yes Yes In the home only 1.47 0.96–2.26 0.078
Yes Yes Outside the home only 3.86 2.33–6.39 <0.001
Yes Yes Inside the home, and prepared outside 
the home
1.59 1.02–2.47 0.042
*OR, odds ratio; CI, confidence interval. 
†ORs adjusted for participant age group and sex; study site; study month; use of acid suppressing medication; self-reported past Campylobacter enteritis; 
recent acquisition of a dog; and frequency of consuming of salads, fruit, vegetables, and unpasteurized milk. 
Figure. Odds ratios (ORs) and 95% confidence intervals (CIs) for 
Campylobacter enteritis associated with chicken consumption, 
England, 2005–2006. Numbers in boxes represent persons in 
each category; Numbers in red are ORs and 95% CIs for relevant 
comparisons; arrows indicate direction of risk. For boxes in the 
bottom level, ORs compare risk for Campylobacter enteritis between 
individuals in that group and the baseline group (labeled), which 
comprises persons who do not regularly eat chicken and did not eat 
chicken in the previous 5 days (n = 334). Model is adjusted for age 
group, sex, study site, and month. *p<0.05; †p<0.01; ‡p<0.001.
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than did persons not reporting past Campylobacter enteritis. 
Compared with all cases, those reporting a previous episode 
of Campylobacter enteritis were of similar age but more 
likely to be female (57% vs. 49%). These persons may dif-
fer in other ways that increase risk, such as medical history 
or immune competence. However, this finding should be 
interpreted cautiously because we had no independent con-
firmation of self-reported Campylobacter enteritis.
Other researchers (11) have suggested that regular con-
sumption of vegetables and legumes might protect against 
infection. However, eating these foods might simply be a 
marker for unmeasured behavior related to decreased risk.
We found no associations with any environmental 
variables. Environmental exposures may pose low or tran-
sient risk; temporal variation in environmental prevalence 
of Campylobacter spp. could make their effects difficult to 
detect. Previous studies in England have identified diabe-
tes as a risk factor for Campylobacter enteritis (9); in our 
study, initial analyses suggested a 1.5-fold increase in ill-
ness associated with diabetes, but this effect disappeared 
after adjustment for other habitual factors.
We did not include persons who reported recent in-
ternational travel because travel-related illness may have 
different risk factors. However, international travel is com-
mon among persons in England with laboratory-confirmed 
Campylobacter infection; 24% of all case-patients reported 
traveling abroad in the previous 14 days compared with 
11% of controls.
Our analysis emphasizes the importance of account-
ing for regular dietary habits in determining risk associated 
with recent consumption of putatively risky foods. More-
over, selection of an appropriate baseline comparison group 
(in this case, persons truly unexposed to chicken consump-
tion) is crucial to enable meaningful comparisons. In the 
future, distinguishing long-term and recent exposures will 
be important in investigating how their association influ-
ences risk. More detailed study of the risks associated with 
chicken prepared at home and in commercial establishments 
is needed. Given the limitations of case–control studies for 
collecting long-term exposure information, innovative stud-
ies using a variety of approaches are necessary.
In England, chicken consumption is the major recog-
nized risk factor for Campylobacter enteritis. Understand-
ing the differing risks from poultry sources should guide 
strategies to reduce risk for infection from chicken. Immu-
nologic factors appear to be important in determining risk 
for Campylobacter enteritis given exposure to infection. 
Meaningful interpretation of Campylobacter risk factor 
studies requires better knowledge of population suscepti-
bility to infection and the extent to which past exposure can 
induce protection. Identifying relevant immune correlates 
would help determine whether differences in immune sta-
tus, behavior, or both are responsible for differing risks for 
Campylobacter enteritis between populations or population 
subgroups.
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